moxalactam has been researched along with Infant, Premature, Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, R; Hashira, S; Maruyama, S; Oka, T; Sanae, N; Sunakawa, K; Takimoto, M; Tojo, M; Tsuchida, A; Yoshioka, H | 1 |
Maruyama, S; Oka, T; Sanae, N; Takimoto, M; Tsuchida, A; Yoshioka, H | 1 |
Chikaoka, H; Hirama, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H | 1 |
Akita, H; Iwasaki, Y; Iwata, S; Kanemitsu, T; Nanri, S; Oikawa, T; Osano, M; Satoh, Y; Sunakawa, K; Tojo, M | 1 |
Hori, M; Kitagawa, M; Kurosu, Y; Sugita, M; Toyonaga, Y | 1 |
Nishimura, T; Tabuki, K; Takashima, T | 1 |
Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K | 1 |
Fujimoto, T; Ishimoto, K; Koga, T; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, N | 1 |
8 other study(ies) available for moxalactam and Infant, Premature, Diseases
Article | Year |
---|---|
[Pharmacokinetic and clinical studies of latamoxef (moxalactam) in neonates and premature infants].
Topics: Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Kinetics; Meningitis, Meningococcal; Moxalactam; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections | 1984 |
[Clinical effect of latamoxef on newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Moxalactam; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Bronchopneumonia; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam; Whooping Cough | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Injections, Intravenous; Male; Moxalactam; Premedication | 1983 |
[Experimental and clinical evaluation latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1983 |
[Pharmacokinetic and clinical studies of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics; Male; Moxalactam | 1983 |
[Evaluation of latamoxef in the treatment of infections of newborn infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Male; Moxalactam; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics; Male; Moxalactam | 1983 |